Candel Therapeutics CADL Income Statement (2020-2026)

NASDAQ CADL
$10.98 +0.10 (+0.92%)
As of: Sep 30, 2026 · 11:43 AM EDT
Reported Financials

Candel Therapeutics Quarterly Income Statement

Periods 24 quarters
Latest Jun 2026

Candel Therapeutics reported net income of -$26.65M for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
11.73M23.33M18.87M28.69M28.89M28.89M28.92M28.92M28.92M28.92M29.09M29.35M31.06M32.13M31.68M49.25M54.89M54.90M54.90M76.12M
Revenue & cost
Revenue
0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Operating items
Research & DevelopmentR&D
3.29M5.26M3.85M5.42M5.02M5.38M4.97M5.47M5.93M5.84M7.26M4.10M4.98M5.42M4.82M4.02M6.99M8.46M11.03M19.80M
Wages, Salaries and OtherWages
1.64M1.87M1.68M1.65M1.72M1.95M1.95M2.02M2.69M
Selling, General & AdministrativeSG&A
2.04M2.79M3.92M3.60M3.76M3.54M3.16M4.16M3.65M3.02M3.06M3.80M3.59M3.34M3.32M4.11M4.19M4.75M4.72M6.95M
Other Operating ExpensesOther Opex
1.67M1.21M2.20M1.19M1.93M3.05M3.85M6.59M13.08M
Operating ExpensesOpex
5.33M8.06M7.77M9.02M8.78M8.91M8.13M9.63M9.58M8.86M10.32M7.90M8.57M8.76M8.14M8.13M11.18M13.21M15.75M26.75M
Operating IncomeOp. Inc
-5.30M-8.03M-7.74M-8.99M-8.75M-8.88M-8.10M-9.63M-9.58M-8.86M-10.32M-7.90M-8.57M-8.76M-8.14M-8.13M-11.18M-13.21M-15.75M-26.75M
EBIT
-5.30M-8.03M-7.74M-8.99M-8.75M-8.88M-8.10M-9.63M-9.58M-8.86M-10.32M-7.90M-8.57M-8.76M-8.14M-8.13M-11.18M-13.21M-15.75M-26.75M
Non-operating items
Non Operating Interest Expenses
0.43M0.52M0.58M0.61M0.64M0.67M0.67M0.65M0.57M0.49M0.39M0.31M0.24M0.16M1.42M1.57M
Interest & Investment IncomeInt & Inv Inc
-0.01M-0.01M-0.01M-0.17M0.07M0.34M0.80M0.71M0.45M0.50M0.41M0.32M0.24M0.24M0.29M0.93M0.93M0.95M1.10M1.67M
Other Non Operating IncomeOther Non Op Inc.
12.37M8.25M-9.20M-8.29M-4.97M-0.37M-2.74M-0.72M-0.14M-0.58M0.48M-0.01M13.34M1.64M5.83M-14.88M-5.69M-1.15M13.52M12.28M
Non Operating IncomeNon Op. Inc.
-11.78M-8.13M9.34M8.11M4.60M0.19M3.02M0.84M-0.04M0.43M-0.78M-0.32M-13.67M-1.89M-5.93M15.51M6.38M1.94M-13.74M-12.16M
Net income details
EBT
-5.32M-8.04M-7.75M-9.16M-9.12M-9.06M-7.88M-9.53M-9.77M-9.03M-10.58M-8.23M-8.90M-9.01M-8.24M-7.50M-10.49M-12.41M-16.07M-26.65M
Profit After TaxPAT
-5.32M-8.04M-7.75M-9.16M-9.12M-9.06M-7.88M-9.53M-9.77M-9.03M-10.58M-8.23M-8.90M-9.01M-8.24M-7.50M-10.49M-12.41M-16.07M-26.65M
Income from Continuing OperationsIncome (Continuing)
-5.32M-8.04M-7.75M-9.16M-9.12M-9.06M-7.88M-9.53M-9.77M-9.03M-10.58M-8.23M-8.90M-9.01M-8.24M-7.50M-10.49M-12.41M-16.07M-26.65M
Consolidated Net IncomeConsol Net Inc.
-5.32M-8.04M-7.75M-9.16M-9.12M-9.06M-7.88M-9.53M-9.77M-9.03M-10.58M-8.23M-8.90M-9.01M-8.24M-7.50M-10.49M-12.41M-16.07M-26.65M
Income towards Parent CompanyParent Net Inc
-17.08M-16.16M1.60M-0.90M-4.15M-8.69M-5.09M-8.80M-9.61M-8.44M-11.10M-8.22M-22.24M-10.65M-14.10M7.40M-4.80M-11.27M-29.50M-38.91M
Net Income towards Common StockholdersNet Income
-17.08M-16.16M1.60M-0.90M-4.15M-8.69M-5.09M-8.80M-9.61M-8.44M-11.10M-8.22M-22.24M-10.65M-14.10M7.40M-4.80M-11.27M-29.50M-38.91M
Additional items
EPS (Basic)
-1.46-0.690.08-0.03-0.14-0.30-0.18-0.30-0.33-0.29-0.38-0.28-0.74-0.33-0.450.15-0.09-0.21-0.56-0.52
EPS (Diluted)
-1.46-0.690.08-0.03-0.14-0.30-0.18-0.30-0.33-0.29-0.38-0.28-0.74-0.33-0.450.14-0.09-0.21-0.56-0.52
Shares Outstanding
11.72M23.33M18.87M28.69M28.81M28.89M28.82M28.92M28.92M28.92M28.94M29.20M29.88M32.01M31.68M50.48M51.49M54.89M52.96M74.13M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
11.72M23.33M18.87M28.69M28.81M28.89M28.82M28.92M28.92M28.92M28.94M29.20M29.88M32.01M31.68M54.77M51.49M54.89M52.96M74.13M
EBITDA
-5.29M-8.01M-7.56M-8.82M-8.57M-8.68M-7.92M-9.40M-9.34M-8.66M-10.03M-7.60M-8.37M-8.56M-7.89M-7.88M-10.98M-13.01M-15.61M-26.55M
Interest ExpensesInt Expense
0.43M0.52M0.58M0.61M0.64M0.67M0.67M0.65M0.57M0.49M0.39M0.31M0.24M0.16M1.42M1.57M

Candel Therapeutics Income Statement API

Pull Candel Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CADL&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY